Dimerization of presenilin-1 in vivo: Suggestion of novel regulatory mechanisms leading to higher order complexes

Biochemical and Biophysical Research Communications

Volumn 301, Issue 1, 2003, Pages 119-126

  Hébert, Sébastien S ^b   Godin, Chantal ^b   Tomiyama, Takami ^a   Mori, Hiroshi ^a   Lévesque, Georges ^b  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

Oligomerization; Presenilin; Protein dimerization; Western blotting; Yeast two hybrid; Secretase

Indexed keywords

DIMER; GAMMA SECRETASE; OLIGOMER; PRESENILIN 1;

ALZHEIMER DISEASE; ARTICLE; CELL CULTURE; CELL STRAIN; CONTROLLED STUDY; DIMERIZATION; DISEASE ASSOCIATION; ENZYME ACTIVITY; GENE MUTATION; HUMAN; HUMAN CELL; IN VIVO STUDY; MOLECULAR WEIGHT; NONHUMAN; OLIGOMERIZATION; ORDO; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DENATURATION; PROTEIN EXPRESSION; REGULATORY MECHANISM;

EID: 0037474505     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)02984-4     Document Type: Article

References (38)

1. Levesque G., Yu G., Nishimura M., Zhang D.M., Levesque L., Yu H., Xu D., Liang Y., Rogaeva E., Ikeda M., Duthie M., Murgolo N., Wang L., VanderVere P., Bayne M.L., Strader C.D., Rommens J.M., Fraser P.E., St George-Hyslop P. Presenilins interact with armadillo proteins including neural-specific plakophilin-related protein and. β -catenin J. Neurochem. 72:1999;999-1008.
2. Sherrington R., Rogaev E.I., Liang Y., Rogaeva E.A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K.et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 375:1995;754-760.
3. De Strooper B., Beullens M., Contreras B., Levesque L., Craessaerts K., Cordell B., Moechars D., Bollen M., Fraser P., George-Hyslop P.S., Van Leuven F. Phosphorylation, subcellular localization, and membrane orientation of the Alzheimer's disease-associated presenilins. J. Biol. Chem. 272:1997;3590-3598.
4. Czech C., Tremp G., Pradier L. Presenilins and Alzheimer's disease: biological functions and pathogenic mechanisms. Prog. Neurobiol. 60:2000;363-384.
5. Johnston J.A., Ward C.L., Kopito R.R. Aggresomes: a cellular response to misfolded proteins. J. Cell Biol. 143:1998;1883-1898.
6. Capell A., Grunberg J., Pesold B., Diehlmann A., Citron M., Nixon R., Beyreuther K., Selkoe D.J., Haass C. The proteolytic fragments of the Alzheimer's disease-associated presenilin-1 form heterodimers and occur as a 100-150-kDa molecular mass complex. J. Biol. Chem. 273:1998;3205-3211.
7. Seeger M., Nordstedt C., Petanceska S., Kovacs D.M., Gouras G.K., Hahne S., Fraser P., Levesque L., Czernik A.J., George-Hyslop P.S., Sisodia S.S., Thinakaran G., Tanzi R.E., Greengard P., Gandy S. Evidence for phosphorylation and oligomeric assembly of presenilin 1. Proc. Natl. Acad. Sci. USA. 94:1997;5090-5094.
8. Yu G., Chen F., Levesque G., Nishimura M., Zhang D.M., Levesque L., Rogaeva E., Xu D., Liang Y., Duthie M., St George-Hyslop P.H., Fraser P.E. The presenilin 1 protein is a component of a high molecular weight intracellular complex that contains. β -catenin J. Biol. Chem. 273:1998;16470-16475.
9. Steiner H., Capell A., Pesold B., Citron M., Kloetzel P.M., Selkoe D.J., Romig H., Mendla K., Haass C. Expression of Alzheimer's disease-associated presenilin-1 is controlled by proteolytic degradation and complex formation. J. Biol. Chem. 273:1998;32322-32331.
10. Yu G., Nishimura M., Arawaka S., Levitan D., Zhang L., Tandon A., Song Y.Q., Rogaeva E., Chen F., Kawarai T., Supala A., Levesque L., Yu H., Yang D.S., Holmes E., Milman P., Liang Y., Zhang D.M., Xu D.H., Sato C., Rogaev E., Smith M., Janus C., Zhang Y., Aebersold R., Farrer L.S., Sorbi S., Bruni A., Fraser P., St George-Hyslop P.A. Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and. β APP processing Nature. 407:2000;48-54.
11. Li Y.M., Lai M.T., Xu M., Huang Q., DiMuzio-Mower J., Sardana M.K., Shi X.P., Yin K.C., Shafer J.A., Gardell S.J. Presenilin 1 is linked with. γ -secretase activity in the detergent solubilized state Proc. Natl. Acad. Sci. USA. 97:2000;6138-6143.
12. Yu G., Chen F., Nishimura M., Steiner H., Tandon A., Kawarai T., Arawaka S., Supala A., Song Y.Q., Rogaeva E., Holmes E., Zhang D.M., Milman P., Fraser P.E., Haass C., George-Hyslop P.S. Mutation of conserved aspartates affects maturation of both aspartate mutant and endogenous presenilin 1 and presenilin 2 complexes. J. Biol. Chem. 275:2000;27348-27353.
13. Thinakaran G., Harris C.L., Ratovitski T., Davenport F., Slunt H.H., Price D.L., Borchelt D.R., Sisodia S.S. Evidence that levels of presenilins (PS1 and PS2) are coordinately regulated by competition for limiting cellular factors. J. Biol. Chem. 272:1997;28415-28422.
14. Van Gassen G., Annaert W., Van Broeckhoven C. Binding partners of Alzheimer's disease proteins: are they physiologically relevant? Neurobiol. Dis. 7:2000;135-151.
15. Kimberly W.T., Xia W., Rahmati T., Wolfe M.S., Selkoe D.J. The transmembrane aspartates in presenilin 1 and 2 are obligatory for. γ -secretase activity and amyloid β -protein generation J. Biol. Chem. 275:2000;3173-3178.
16. Aldudo J., Bullido M.J., Frank A., Valdivieso F. Missense mutation E318G of the presenilin-1 gene appears to be a nonpathogenic polymorphism. Ann. Neurol. 44:1998;985-986.
17. Vidal R., Ghiso J., Wisniewski T., Frangione B. Alzheimer's presenilin 1 gene expression in platelets and megakaryocytes. Identification of a novel splice variant. FEBS Lett. 393:1996;19-23.
18. Cruts M., Hendriks L., Van Broeckhoven C. The presenilin genes: a new gene family involved in Alzheimer disease pathology. Hum. Mol. Genet. 5:1996;1449-1455.
19. Ratovitski T., Slunt H.H., Thinakaran G., Price D.L., Sisodia S.S., Borchelt D.R. Endoproteolytic processing and stabilization of wild-type and mutant presenilin. J. Biol. Chem. 272:1997;24536-24541.
20. Steiner H., Romig H., Grim M.G., Philipp U., Pesold B., Citron M., Baumeister R., Haass C. The biological and pathological function of the presenilin-1 Deltaexon 9 mutation is independent of its defect to undergo proteolytic processing. J. Biol. Chem. 274:1999;7615-7618.
21. Okochi M., Sahara N., Kametani F., Usami M., Arai T., Tanaka K., Ishii K., Yamamoto A., Mori H. Presenilin 1 cleavage is a universal event in human organs. Neurobiol. Aging. 19:1998;S3-S10.
22. Steiner H., Romig H., Pesold B., Philipp U., Baader M., Citron M., Loetscher H., Jacobsen H., Haass C. Amyloidogenic function of the Alzheimer's disease-associated presenilin 1 in the absence of endoproteolysis. Biochemistry. 38:1999;14600-14605.
23. Overton M.C., Blumer K.J. G-protein-coupled receptors function as oligomers in vivo. Curr. Biol. 10:2000;341-344.
24. 2 -adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation J. Biol. Chem. 271:1996;16384-16392.
25. Honda T., Yasutake K., Nihonmatsu N., Mercken M., Takahashi H., Murayama O., Murayama M., Sato K., Omori A., Tsubuki S., Saido T.C., Takashima A. Dual roles of proteasome in the metabolism of presenilin 1. J. Neurochem. 72:1999;255-261.
26. Dewji N.N., Singer S.J. Cell surface expression of the Alzheimer disease-related presenilin proteins. Proc. Natl. Acad. Sci. USA. 94:1997;9926-9931.
27. Benussi L., Alberici A., Mayhaus M., Langer U., Ghidoni R., Mazzoli F., Nicosia F., Barbiero L., Frisoni G., Zanetti O., Gasparini L., Nitsch R.M., Binetti G. Detection of the presenilin 1 COOH-terminal fragment in the extracellular compartment: a release enhanced by apoptosis. Exp. Cell Res. 269:2001;256-265.
28. Weber L.L., Leissring M.A., Yang A.J., Glabe C.G., Cribbs D.H., LaFerla F.M. Presenilin-1 immunoreactivity is localized intracellularly in Alzheimer's disease brain, but not detected in amyloid plaques. Exp. Neurol. 143:1997;37-44.
29. Yamamoto A., Sahara N., Usami M., Okochi M., Kondo T., Kametani F., Tanaka K., Yahagi Y., Shirasawa T., Itoyama Y., Mori H. Abnormal gel-electrophoretic behavior of presenilin 1 and it's fragment. Biochem. Biophys. Res. Commun. 226:1996;536-541.
30. Sahara N., Yahagi Y., Takagi H., Kondo T., Okochi M., Usami M., Shirasawa T., Mori H. Identification and characterization of presenilin I-467, I-463 and I- 374. FEBS Lett. 381:1996;7-11.
31. Ingano L.A., Lentini K.M., Kovacs I., Tanzi R.E., Kovacs D.M. Cytoplasmic presenilin aggregates in proteasome inhibitor-treated cells. Ann. NY Acad. Sci. 920:2000;259-260.
32. Cervantes S., Gonzalez-Duarte R., Marfany G. Homodimerization of presenilin N-terminal fragments is affected by mutations linked to Alzheimer's disease. FEBS Lett. 505:2001;81-86.
33. Saura C.A., Tomita T., Davenport F., Harris C.L., Iwatsubo T., Thinakaran G. Evidence that intramolecular associations between presenilin domains are obligatory for endoproteolytic processing. J. Biol. Chem. 274:1999;13818-13823.
34. Duff K., Eckman C., Zehr C., Yu X., Prada C.M., Perez-tur J., Hutton M., Buee L., Harigaya Y., Yager D., Morgan D., Gordon M.N., Holcomb L., Refolo L., Zenk B., Hardy J., Younkin S. Increased amyloid-. β 42(43) in brains of mice expressing mutant presenilin 1 Nature. 383:1996;710-713.
35. Davis J.A., Naruse S., Chen H., Eckman C., Younkin S., Price D.L., Borchelt D.R., Sisodia S.S., Wong P.C. An Alzheimer's disease-linked PS1 variant rescues the developmental abnormalities of PS1-deficient embryos. Neuron. 20:1998;603-609.
36. Shen J., Bronson R.T., Chen D.F., Xia W., Selkoe D.J., Tonegawa S. Skeletal and CNS defects in Presenilin-1-deficient mice. Cell. 89:1997;629-639.
37. Donoviel D.B., Hadjantonakis A.K., Ikeda M., Zheng H., Hyslop P.S., Bernstein A. Mice lacking both presenilin genes exhibit early embryonic patterning defects. Genes Dev. 13:1999;2801-2810.
38. Golde T.E., Younkin S.G. Presenilins as therapeutic targets for the treatment of Alzheimer's disease. Trends Mol. Med. 7:2001;264-269.